Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Corporation stock logo
CNMD
CONMED
$53.47
-1.6%
$52.34
$46.00
$78.19
$1.68B1.18435,512 shs299,242 shs
Enovis Corporation stock logo
ENOV
Enovis
$30.88
-0.1%
$30.06
$25.47
$49.83
$1.77B1.681.06 million shs876,352 shs
NovoCure Limited stock logo
NVCR
NovoCure
$12.19
-1.1%
$14.05
$10.87
$34.13
$1.38B0.581.45 million shs1.20 million shs
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$29.37
-0.9%
$36.84
$21.77
$81.56
$438.81M1.39529,760 shs602,968 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Corporation stock logo
CNMD
CONMED
-1.61%-2.14%+2.34%-5.41%-26.97%
Enovis Corporation stock logo
ENOV
Enovis
0.00%-1.00%+19.98%-3.04%-33.73%
NovoCure Limited stock logo
NVCR
NovoCure
-1.14%+3.04%+7.69%-27.09%-37.29%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-0.91%-4.61%-14.77%-17.87%+10.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Corporation stock logo
CNMD
CONMED
4.6103 of 5 stars
2.13.02.54.33.90.03.1
Enovis Corporation stock logo
ENOV
Enovis
4.3714 of 5 stars
4.52.00.00.04.03.31.9
NovoCure Limited stock logo
NVCR
NovoCure
3.989 of 5 stars
3.32.00.04.52.13.30.0
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
3.4629 of 5 stars
3.64.00.00.02.51.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Corporation stock logo
CNMD
CONMED
2.20
Hold$59.8011.84% Upside
Enovis Corporation stock logo
ENOV
Enovis
3.00
Buy$51.0065.14% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.57
Moderate Buy$28.79136.14% Upside
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
3.25
Buy$81.75178.35% Upside

Current Analyst Ratings Breakdown

Latest SMLR, ENOV, CNMD, and NVCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$70.00 ➝ $58.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$65.00 ➝ $57.00
8/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$48.00 ➝ $41.00
8/7/2025
Enovis Corporation stock logo
ENOV
Enovis
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$57.00 ➝ $49.00
8/6/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$61.00 ➝ $60.00
7/31/2025
CONMED Corporation stock logo
CNMD
CONMED
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$80.00 ➝ $68.00
7/28/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$61.00
7/28/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$61.00
7/25/2025
NovoCure Limited stock logo
NVCR
NovoCure
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$40.00 ➝ $14.50
7/9/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$95.00
7/8/2025
Enovis Corporation stock logo
ENOV
Enovis
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$48.00 ➝ $46.00
(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Corporation stock logo
CNMD
CONMED
$1.31B1.27$6.61 per share8.09$32.40 per share1.65
Enovis Corporation stock logo
ENOV
Enovis
$2.11B0.84$19.18 per share1.61$45.15 per share0.68
NovoCure Limited stock logo
NVCR
NovoCure
$605.22M2.25N/AN/A$3.13 per share3.89
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$56.29M7.73$4.44 per share6.62$25.90 per share1.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Corporation stock logo
CNMD
CONMED
$132.42M$3.5315.1510.551.858.31%14.43%6.05%10/29/2025 (Estimated)
Enovis Corporation stock logo
ENOV
Enovis
-$825.49M-$14.25N/A9.68N/A-37.80%6.78%3.73%11/5/2025 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%10/29/2025 (Estimated)
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$40.90M$2.4312.09N/A86.20%43.84%32.88%11/3/2025 (Estimated)

Latest SMLR, ENOV, CNMD, and NVCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Enovis Corporation stock logo
ENOV
Enovis
$0.74$0.79+$0.05-$0.64$555.80 million$564.50 million
8/4/2025Q2 2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-$0.27$5.04+$5.31$5.04$8.10 million$8.22 million
7/30/2025Q2 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.13$1.15+$0.02$0.69$338.42 million$342.35 million
7/24/2025Q2 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.39-$0.36+$0.03-$0.36$153.87 million$158.80 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Corporation stock logo
CNMD
CONMED
$0.801.50%N/A22.66%N/A
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
N/AN/AN/AN/AN/A

Latest SMLR, ENOV, CNMD, and NVCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.5%9/15/20259/15/202510/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Corporation stock logo
CNMD
CONMED
0.88
2.23
1.00
Enovis Corporation stock logo
ENOV
Enovis
0.53
2.25
1.15
NovoCure Limited stock logo
NVCR
NovoCure
0.28
1.45
1.39
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
0.25
0.60
0.58

Institutional Ownership

CompanyInstitutional Ownership
CONMED Corporation stock logo
CNMD
CONMED
N/A
Enovis Corporation stock logo
ENOV
Enovis
98.45%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
49.37%

Insider Ownership

CompanyInsider Ownership
CONMED Corporation stock logo
CNMD
CONMED
3.10%
Enovis Corporation stock logo
ENOV
Enovis
2.70%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
16.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.95 million30.00 millionOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,36757.16 million55.62 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,488111.80 million105.63 millionOptionable
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
12014.81 million12.38 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CONMED stock logo

CONMED NYSE:CNMD

$53.47 -0.89 (-1.64%)
Closing price 09/2/2025 03:59 PM Eastern
Extended Trading
$53.57 +0.10 (+0.19%)
As of 09/2/2025 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Enovis stock logo

Enovis NYSE:ENOV

$30.88 -0.02 (-0.06%)
Closing price 09/2/2025 03:59 PM Eastern
Extended Trading
$30.68 -0.20 (-0.66%)
As of 09:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$12.19 -0.14 (-1.14%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$12.16 -0.04 (-0.29%)
As of 09:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Semler Scientific stock logo

Semler Scientific NASDAQ:SMLR

$29.37 -0.27 (-0.91%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$29.68 +0.31 (+1.07%)
As of 09:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.